Population PKS & PDS of tamsulosin, in patients with benign prostatic hyperplasia (BPH)

被引:0
|
作者
Forrest, A
Collins, DA
Shore, RM
Rubino, CM
Yasukawa, K
Tajima, Y
Ito, Y
机构
[1] SUNY BUFFALO,SCH PHARM,BUFFALO,NY
[2] SUNY BUFFALO,CLIN PHARMACOKINET LAB,BUFFALO,NY
[3] YAMANOUCHI USA INC,WHITE PLAINS,NY
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:PI98 / PI98
页数:1
相关论文
共 50 条
  • [41] DEVELOPMENT OF A MODEL FOR CANINE BENIGN PROSTATIC HYPERPLASIA (BPH)
    WADE, DR
    FALVO, RE
    JOURNAL OF ANDROLOGY, 1982, 3 (01): : 35 - 35
  • [42] Risk stratification for benign prostatic hyperplasia (BPH) treatment
    Emberton, Mark
    Fitzpatrick, John M.
    Rees, Jon
    BJU INTERNATIONAL, 2011, 107 (06) : 876 - 880
  • [43] URODYNAMICS (UDS) USAGE FOR BENIGN PROSTATIC HYPERPLASIA (BPH)
    Thorogood, Samantha L.
    Zhang, Tenny R.
    Sze, Christina
    Strasser, Mary O.
    Demeo, Gina
    Lee, Richard K.
    Chughtai, Bilal
    Te, Alexis
    Hu, Jim C.
    JOURNAL OF UROLOGY, 2022, 207 (05): : E303 - E304
  • [44] Minimally Invasive Treatment in Benign Prostatic Hyperplasia (BPH)
    Sciacqua, L. V.
    Vanzulli, A.
    Di Meo, R.
    Pellegrino, G.
    Lavorato, R.
    Vitale, G.
    Carrafiello, G.
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2023, 22
  • [45] PRINCIPLES OF ENDOCRINE MANAGEMENT OF BENIGN PROSTATIC HYPERPLASIA (BPH)
    ELETREBY, MF
    HABENICHT, UF
    ANTICANCER RESEARCH, 1986, 6 (03) : 391 - 392
  • [46] The role of inflammation in the etiopathogenesis of Benign Prostatic Hyperplasia (BPH)
    Tekin, Ali
    UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2011, 10 (04): : 15 - 19
  • [47] Non-inferiority of silodosin to tamsulosin in treating patients with lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH)
    Yu, Hong-Jeng
    Lin, Alex Tong-Long
    Yang, Stephen Shei-Dei
    Tsui, Ke-Hung
    Wu, Hsi-Chin
    Cheng, Chen-Li
    Cheng, Hong-Lin
    Wu, Tony T.
    Chiang, Po-Hui
    BJU INTERNATIONAL, 2011, 108 (11) : 1843 - 1848
  • [48] Herbal medications in the treatment of benign prostatic hyperplasia (BPH)
    Fagelman, E
    Lowe, FC
    UROLOGIC CLINICS OF NORTH AMERICA, 2002, 29 (01) : 23 - +
  • [49] ALPHA-BLOCKADE FOR BENIGN PROSTATIC HYPERPLASIA (BPH)
    LEPOR, H
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (03): : 750 - 753
  • [50] Macrophage infiltration of the stroma in benign prostatic hyperplasia (BPH)
    Gurski, L. A.
    Pascal, L. E.
    Nelson, J. B.
    Pilch, J.
    Wang, Z.
    MOLECULAR BIOLOGY OF THE CELL, 2014, 25